| Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue MJ Gerdes, CJ Sevinsky, A Sood, S Adak, MO Bello, A Bordwell, A Can, ... Proceedings of the National Academy of Sciences 110 (29), 11982-11987, 2013 | 753 | 2013 |
| Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same BF Spielvogel, A Sood, IH Hall, BR Shaw US Patent 5,130,302, 1992 | 655 | 1992 |
| Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates BF Spielvogel, A Sood, IH Hall, BR Shaw US Patent 5,455,233, 1995 | 641 | 1995 |
| Boronated phosphoramidate compounds BF Spielvogel, A Sood US Patent 5,272,250, 1993 | 351 | 1993 |
| Process for preparing oligoribonucleoside and oligodeoxyribonucleoside boranophosphates BF Spielvogel, A Sood, IH Hall, BR Shaw US Patent 5,177,198, 1993 | 285 | 1993 |
| Single nucleotide amplification and detection by polymerase J Nelson, C Fuller, A Sood, S Kumar US Patent 7,033,762, 2006 | 257 | 2006 |
| Labeled nucleoside polyphosphates S Kumar, A Sood US Patent 7,041,812, 2006 | 256 | 2006 |
| Boron-containing nucleic acids. 2. Synthesis of oligodeoxynucleoside boranophosphates A Sood, BR Shaw, BF Spielvogel Journal of the American Chemical Society 112 (24), 9000-9001, 1990 | 231 | 1990 |
| Sequential analysis of biological samples A Sood, JR Nelson, MJ Gerdes US Patent 9,201,063, 2015 | 194 | 2015 |
| Terminal-phosphate-labeled nucleotides and methods of use C Fuller, S Kumar, A Sood, J Nelson US Patent 7,223,541, 2007 | 192 | 2007 |
| Terminal-phosphate-labeled nucleotides and methods of use J Nelson, C Fuller, A Sood, S Kumar US Patent 7,052,839, 2006 | 181 | 2006 |
| Analyte detection A Sood, S Kumar, C Fuller, J Nelson US Patent 7,244,566, 2007 | 176 | 2007 |
| Terminal-phosphate-labeled nucleotides with new linkers S Kumar, M McDougall, A Sood, J Nelson, C Fuller, J Macklin, P Mitsis US Patent 7,393,640, 2008 | 150 | 2008 |
| Emerging understanding of multiscale tumor heterogeneity MJ Gerdes, A Sood, C Sevinsky, AD Pris, MI Zavodszky, F Ginty Frontiers in oncology 4, 366, 2014 | 134 | 2014 |
| Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma A Rajan, CR Heery, A Thomas, AL Mammen, S Perry, GOS Coyne, ... Journal for immunotherapy of cancer 7 (1), 1-12, 2019 | 130 | 2019 |
| Solid phase sequencing A Sood, S Kumar, J Nelson, C Fuller US Patent App. 10/773,000, 2004 | 112 | 2004 |
| Terminal phosphate labeled nucleotides: synthesis, applications, and linker effect on incorporation by DNA polymerases S Kumar, A Sood, J Wegener, PJ Finn, S Nampalli, JR Nelson, A Sekher, ... Nucleosides, Nucleotides and Nucleic Acids 24 (5-7), 401-408, 2005 | 103 | 2005 |
| 5′‐P‐Borane‐Substituted Thymidine Monophosphate and Triphosphate J Tomasz, BR Shaw, K Porter, BF Spielvogel, A Sood Angewandte Chemie International Edition in English 31 (10), 1373-1375, 1992 | 103 | 1992 |
| Terminal phosphate blocked nucleoside polyphosphates A Sood, S Kumar, C Fuller, J Nelson US Patent 7,256,019, 2007 | 99 | 2007 |
| Terminal phosphate-labeled nucleotides with improved substrate properties for homogeneous nucleic acid assays A Sood, S Kumar, S Nampalli, JR Nelson, J Macklin, CW Fuller Journal of the American Chemical Society 127 (8), 2394-2395, 2005 | 99 | 2005 |
